Ifp Advisors, Inc Genetic Technologies LTD Transaction History

Ifp Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$0.0 - $0.01 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$0.0 - $0.02 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$0.0 - $0.01 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$0.0 - $0.0 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$0.0 - $0.0 $0 - $0	0 New
Q2 2020 Aug 05, 2020	BUY	$0.0 - $0.0 $0 - $0	0 New
Q1 2020 May 12, 2020	BUY	$0.0 - $0.0 $0 - $0	0 New
Q4 2019 Jan 17, 2020	BUY	$0.0 - $0.0 $0 - $0	0 New
Q3 2019 Nov 07, 2019	BUY	$0.0 - $0.0 $0 - $0	0 New

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.